Cargando…
Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells
The WNT-TCF signaling pathway participates in adult tissue homeostasis and repair, and is hyperactive in a number of human diseases including cancers of the colon. Whereas to date there are no antagonists approved for patient use, a potential problem for their sustained use is the blockade of WNT si...
Autores principales: | Seth, Chandan, Mas, Christophe, Conod, Arwen, Mueller, Jens, Siems, Karsten, Kuciak, Monika, Borges, Isabel, Ruiz i Altaba, Ariel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156407/ https://www.ncbi.nlm.nih.gov/pubmed/27973612 http://dx.doi.org/10.1371/journal.pone.0168170 |
Ejemplares similares
-
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12
por: Duquet, Arnaud, et al.
Publicado: (2014) -
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
por: Melotti, Alice, et al.
Publicado: (2014) -
In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases
por: Singovski, Grigori, et al.
Publicado: (2016) -
Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner
por: Kuciak, Monika, et al.
Publicado: (2019) -
Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling
por: Seth, Chandan, et al.
Publicado: (2016)